From Dynamic Combinatorial Chemistry to in Vivo Evaluation of Reversible and Irreversible Myeloperoxidase Inhibitors.

The implementation of dynamic combinatorial libraries allowed the determination of highly active reversible and irreversible inhibitors of myeloperoxidase (MPO) at the nanomolar level. Docking experiments highlighted the interaction between the most active ligands and MPO, and further kinetic studies defined the mode of inhibition of these compounds. Finally, in vivo evaluation showed that one dose of irreversible inhibitors is able to suppress the activity of MPO after inducing inflammation.

[1]  C. Obinger,et al.  Characterization of chemical features of potent myeloperoxidase inhibitors. , 2016, Future medicinal chemistry.

[2]  V. Vasić,et al.  Myeloperoxidase Inhibitors as Potential Drugs. , 2015, Current drug metabolism.

[3]  C. Cross,et al.  Inhibition of myeloperoxidase: evaluation of 2H-indazoles and 1H-indazolones. , 2014, Bioorganic & medicinal chemistry.

[4]  C. Obinger,et al.  Hybrid molecules inhibiting myeloperoxidase activity and serotonin reuptake: a possible new approach of major depressive disorders with inflammatory syndrome , 2014, The Journal of pharmacy and pharmacology.

[5]  D. Dimasi,et al.  Neutrophil interactions with the vascular endothelium. , 2013, International immunopharmacology.

[6]  Piotr Nowak,et al.  Dynamic combinatorial libraries: from exploring molecular recognition to systems chemistry. , 2013, Journal of the American Chemical Society.

[7]  C. Obinger,et al.  Evaluation of new scaffolds of myeloperoxidase inhibitors by rational design combined with high-throughput virtual screening. , 2012, Journal of medicinal chemistry.

[8]  O. Augusto,et al.  MPO Inhibitors Selected by Virtual Screening , 2011, Molecular informatics.

[9]  A. Kettle,et al.  Serotonin as a physiological substrate for myeloperoxidase and its superoxide-dependent oxidation to cytotoxic tryptamine-4,5-dione. , 2009, The Biochemical journal.

[10]  C. Obinger,et al.  Myeloperoxidase: a target for new drug development? , 2007, British journal of pharmacology.

[11]  S. Klebanoff.  Myeloperoxidase: friend and foe , 2005, Journal of leukocyte biology.

[12]  Olof Ramström,et al.  Drug discovery by dynamic combinatorial libraries , 2002, Nature Reviews Drug Discovery.

[13]  M. Kurzer,et al.  Indomethacin decreases carrageenan-induced peritoneal adhesions. , 1988, Surgery.